Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis

Archives of Internal Medicine

Volumn 157, Issue 7, 1997, Pages 792-796

  Cicognani, Camilla ^a   Malavolti, Mauro ^a   Morselli Labate, Antonio Maria ^a   Zamboni, Luisella ^a   Sama, Claudia ^a   Barbara, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030998696     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.7.792     Document Type: Article

References (37)

1. McIntyre N. Plasma lipids and lipoproteins in liver disease. Gut 1978;19:526-530.
2. Kroon PA, Powell EE. Liver, lipoprotein and disease, I: biochemistry of lipoprotein metabolism. J Gastroenterol Hepatol. 1992;7:214-224.
3. Kanel G, Radvan G, Peters RL. High-density lipoprotein cholesterol and liver disease. Hepatology. 1983;3:343-348.
4. Levy RI, Rifkind BM. The structure, function and metabolism of high-density lipoproteins: a status report. Circulation. 1980;62(suppl):4-8.
5. Wu AL, Windmueller HG. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem. 1979;254:7316-7322.
6. Glickman RM, Sabesin SM. Lipoprotein metabolism. In: Arias I, Jacoby W, Popper H, Schachter D, Shafits D, eds. The Liver Biology and Pathobiology. New York, NY: Raven Press; 1988:123-142.
7. Powell E, Kroon P. Liver, lipoproteins and disease, II: clinical relevance of disordered cholesterol metabolism in liver disease. J Gastroenterol Hepatol. 1992;7:225-231.
8. Cooper AD, Hepatic clearance of plasma chylomicron remnants. Semin Liver Dis. 1992;12:386-396.
9. Jahn CE, Schaefer EJ, Taam LA, et al. Lipoprotein abnormalities in primary biliary cirrhosis: association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology. 1985;89:1266-1278.
10. Koga S, Miyata Y, Ibayashi H. Plasma lipoproteins and apoproteins in primary biliary cirrhosis. Hepatology. 1985;5:286-292.
11. Gallin JI, Kaye D, O'Leary WM, Serum lipids in infection. N Engl J Med. 1969;281:1081-1086.
12. Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology. 1984;4:430-435.
13. Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol. 1989;24:269-276.
14. Sherlock S, Dooley J. Chronic hepatitis. In: Diseases of the Liver and Biliary System. 9th ed, Cambridge, Mass: Blackwell Publishers: 1993:306.
15. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12:671-675.
16. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J. 1987;8:77-88.
17. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
18. Bergmaier H. Methoden der Enzymatischen Analyses. 3rd ed. Weinheim, Germany: Verlag Chenue; 1974;2:1878.
19. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
20. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
21. Thompson GR. A Handbook of Hyperlipidaemia, London, England: Merck & Co; 1990:3-39.
22. Rej R. Measurement of aminotransferase, I: aspartate aminotransferase. Crit Rev Clin Lab Sci. 1984;21:99-186.
23. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362-364.
24. Snedecor GW, Cochran WG. Statistical Methods. 8th ed, Ames: Iowa State University Press; 1989.
25. Siegel S. Nonparametric Statistics for the Behavioral Sciences. New York, NY: McGraw-Hill Book Co; 1956:47-52.
26. Palombo JD, Lopes SM, Zeisel SH, et al. Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Gastroenterology. 1987;93:1170-1177.
27. Zimmermann T, Franke H, Peuker M, Dargel R. Quantitative studies on fatty acid metabolism in isolated parenchymal cells from normal and cirrhotic livers in rats. J Hepatol. 1992;15:10-16.
28. Nosadini R, Avogaro A, Mollo F, et al. Carbohydrate and lipid metabolism in cirrhosis: evidence that hepatic uptake of gluconeogenic precursors and free fatty acids depends on effective hepatic flow. J Clin Endocrinol Metab. 1984;58:1125-1132.
29. Starzl T, Chase H, Putnam C, Porter K. Portacaval shunt in hyperlipoproteinaemia. Lancet 1973;2:940-944.
30. Chan L. Apolipoprotein B, the major protein component of triglyceride-rich and low-density lipoprotein. J Biol Chem. 1992;267:25621-25624.
31. Merli M, Riggio O, Romiti A, et al. Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology. 1990;12:106-112.
32. Muller MJ, Lautz UH, Plogmann B, Burger M, Korber J, Schmidt F. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology. 1992;15:782-794.
33. Villeneuve J, Infante-Rivard C, Ampelas M, et al. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology. 1986;6:928-931.
34. Beuers U, Jager F, Wahllander A, Ansari H, Kirsch C. Prognostic value of the intravenous 14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion. 1991;50:212-218.
35. Festi D, Morselli-Labate AM, Roda A, et al. Diagnostic effectiveness of serum bile acids in liver diseases as evaluated by multivariate statistical methods. Hepatology. 1983;3:707-713.
36. Mannes G, Thieme C, Stellaard F, et al. Prognostic significance of serum bile acids in cirrhosis. Hepatology. 1986;6:50-53.
37. Zoli M, Cordiani MR, Marchesini G, et al. Prognostic indicators in compensated cirrhosis, Am J Gastroenterol. 1991;86:1508-1513.